title: Cyclic AMP level of lymphocytes in patients with systemic lupus erythematosus and its relation to disease activity.
abstract: The basal and stimulated intracellular cyclic AMP (cAMP) levels of peripheral blood mononuclear cells (PBMC) of 16 control subjects and 14 patients with systemic lupus erythematosus (SLE), all fulfilling the ARA criteria, were studied. No significant difference in basal cAMP level was observed between SLE patients and controls. SLE lymphocytes (both active and inactive) elicited a diminished response to aminophylline and prostaglandin E2 (PGE2). No correlation was seen between disease activity and either baseline cAMP levels or response to these stimulators. We suggest an intrinsic (not disease activity-related) impairment of the adenylate cyclase-dependent regulatory mechanism in the PBMC of SLE patients, which may result in a defective IL-2 production and IL-2 dependent biological functions.
authors.affiliation: Second Department of Medicine, Semmelweis University, Budapest, Hungary.
authors.forename: N C
authors.initials: NC
authors.lastname: Phi
authors.forename: A
authors.initials: A
authors.lastname: Takáts
authors.forename: V H
authors.initials: VH
authors.lastname: Binh
authors.forename: C V
authors.initials: CV
authors.lastname: Vien
authors.forename: R
authors.initials: R
authors.lastname: González-Cabello
authors.forename: P
authors.initials: P
authors.lastname: Gergely
mesh_terms: D000628:Aminophylline / Q000494:pharmacology; D000242:Cyclic AMP / Q000097:blood*; D015232:Dinoprostone / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000096:biosynthesis; D008180:Lupus Erythematosus, Systemic / Q000097:blood*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*
chemical_list: D007376:Interleukin-2; D000628:Aminophylline; D000242:Cyclic AMP; D015232:Dinoprostone